Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement.
This study investigated the in vitro nail permeability of penetrants of varying lipophilicity-caffeine (CF, logP -0.07), methylparaben (MP, logP 1.96) and terbinafine (TBF, logP 3.3) and the effect of 2 novel penetration enhancers (PEs), thioglycolic acid (TA) and urea hydrogen peroxide (urea H(2)O(2)) on their permeation. Studies were conducted using full thickness human nail clippings and ChubTur((R)) diffusion cells and penetrants were applied as saturated solutions. The rank order of steady-state penetrant flux through nails without PE application (MP>CF>TBF) suggested a greater sensitivity to penetrant molecular weight rather than logP. TA increased the flux of CF and MP approximately 4- and approximately 2-fold, respectively, whilst urea H(2)O(2) proved ineffective at enhancing permeability. The sequential application of TA followed by urea H(2)O(2) increased TBF and CF flux ( approximately 19- and approximately 4-fold, respectively) but reversing the application order of the PEs was only mildly effective at increasing just MP flux ( approximately 2-fold). Both nail PEs are likely to function via disruption of keratin disulphide bonds and the associated formation of pores that provide more 'open' drug transport channels. Effects of the PEs were penetrant specific, but the use of a reducing agent (TA) followed by an oxidising agent (urea H(2)O(2)) dramatically improved human nail penetration.
Brown
M B
MB
School of Pharmacy, University of Hertfordshire, College Lane, Hatfield, Herts AL10 9AB, UK.
Khengar
R H
RH
Turner
R B
RB
Forbes
B
B
Traynor
M J
MJ
Evans
C R G
CR
Jones
S A
SA
D000042:Absorption; D000277:Adjuvants, Pharmaceutic / Q000737:chemistry*; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D002110:Caffeine / Q000737:chemistry / Q000493:pharmacokinetics; D000077463:Carbamide Peroxide; D002626:Chemistry, Pharmaceutical; D015194:Diffusion Chambers, Culture; D004338:Drug Combinations; D004339:Drug Compounding; D016503:Drug Delivery Systems; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008875:Middle Aged; D009262:Nails / Q000187:drug effects / Q000378:metabolism*; D009281:Naphthalenes / Q000737:chemistry / Q000493:pharmacokinetics; D010226:Parabens / Q000737:chemistry / Q000493:pharmacokinetics; D010539:Permeability; D010545:Peroxides / Q000737:chemistry*; D000077291:Terbinafine; D013864:Thioglycolates / Q000737:chemistry*; D014508:Urea / Q000031:analogs & derivatives* / Q000737:chemistry
D000277:Adjuvants, Pharmaceutic; D004338:Drug Combinations; D009281:Naphthalenes; D010226:Parabens; D010545:Peroxides; D013864:Thioglycolates; D000077463:Carbamide Peroxide; D002110:Caffeine; D014508:Urea; C015358:methylparaben; D000077291:Terbinafine